Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 191

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017

Open access
Giri, Veda N., Knudsen, Karen E., Kelly, William K., Abida, Wassim, Andriole, Gerald L., Bangma, Chris H., Bekelman, Justin E., Benson, Mitchell C., Blanco, Amie, Burnett, Arthur, Catalona, William J., Cooney, Kathleen A., Cooperberg, Matthew, Crawford, David E., Den, Robert B., Dicker, Adam P., Eggener, Scott, Fleshner, Neil, Freedman, Matthew L., Hamdy, Freddie C., Hoffman-Censits, Jean, Hurwitz, Mark D., Hyatt, Colette, Isaacs, William B., Kane, Christopher J., Kantoff, Philip, Karnes, R. Jeffrey, Karsh, Lawrence I., Klein, Eric A., Lin, Daniel W., Loughlin, Kevin R., Lu-Yao, Grace, Malkowicz, S. Bruce, Mann, Mark J., Mark, James R., McCue, Peter A., Miner, Martin M., Morgan, Todd, Moul, Judd W., Myers, Ronald E., Nielsen, Sarah M., Obeid, Elias, Pavlovich, Christian P., Peiper, Stephen C., Penson, David F., Petrylak, Daniel, Pettaway, Curtis A., Pilarski, Robert, Pinto, Peter A., Poage, Wendy, Raj, Ganesh V., Rebbeck, Timothy R., Robson, Mark E., Rosenberg, Matt T., Sandler, Howard, Sartor, Oliver, Schaeffer, Edward, Schwartz, Gordon F., Shahin, Mark S., Shore, Neal D., Shuch, Brian, Soule, Howard R., Tomlins, Scott A., Trabulsi, Edouard J., Uzzo, Robert, Vander Griend, Donald J., Walsh, Patrick C., Weil, Carol J., Wender, Richard, Gomella, Leonard G. · 2018 · Journal of Clinical Oncology

Abstract

Purpose: Guidelines are limited for genetic testing for prostate cancer (PCA). The goal of this conference was to develop an expert consensus-driven working framework for comprehensive genetic evaluation of inherited PCA in the multigene testing era addressing genetic counseling, testing, and genetically informed management. Methods: An expert consensus conference was convened including key stakeholders to address genetic counseling and testing, PCA screening, and management informed by evidence review. Results: Consensus was strong that patients should engage in shared decision making for genetic testing. There was strong consensus to test HOXB13 for suspected hereditary PCA, BRCA1/2 for suspected hereditary breast and ovarian cancer, and DNA mismatch repair genes for suspected Lynch syndrome. There was strong consensus to factor BRCA2 mutations into PCA screening discussions. BRCA2 achieved moderate consensus for factoring into early-stage management discussion, with stronger consensus in high-risk/advanced and metastatic setting. Agreement was moderate to test all men with metastatic castration-resistant PCA, regardless of family history, with stronger agreement to test BRCA1/2 and moderate agreement to test ATM to inform prognosis and targeted therapy. Conclusion: To our knowledge, this is the first comprehensive, multidisciplinary consensus statement to address a genetic evaluation framework for inherited PCA in the multigene testing era. Future research should focus on developing a working definition of familial PCA for clinical genetic testing, expanding understanding of genetic contribution to aggressive PCA, exploring clinical use of genetic testing for PCA management, genetic testing of African American males, and addressing the value framework of genetic evaluation and testing men at risk for PCA—a clinically heterogeneous disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2017.74.1173

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 191

Metadata

Authors
Giri, V. N., Knudsen, K. E., Kelly, W. K., Abida, W., Andriole, G. L., Bangma, C. H., Bekelman, J. E., Benson, M. C., Blanco, A., Burnett, A., Catalona, W. J., Cooney, K. A., Cooperberg, M., Crawford, D. E., Den, R. B., Dicker, A. P., Eggener, S., Fleshner, N., Freedman, M. L., Hamdy, F. C., Hoffman-Censits, J., Hurwitz, M. D., Hyatt, C., Isaacs, W. B., Kane, C. J., Kantoff, P., Karnes, R. J., Karsh, L. I., Klein, E. A., Lin, D. W., Loughlin, K. R., Lu-Yao, G., Malkowicz, S. B., Mann, M. J., Mark, J. R., McCue, P. A., Miner, M. M., Morgan, T., Moul, J. W., Myers, R. E., Nielsen, S. M., Obeid, E., Pavlovich, C. P., Peiper, S. C., Penson, D. F., Petrylak, D., Pettaway, C. A., Pilarski, R., Pinto, P. A., Poage, W., Raj, G. V., Rebbeck, T. R., Robson, M. E., Rosenberg, M. T., Sandler, H., Sartor, O., Schaeffer, E., Schwartz, G. F., Shahin, M. S., Shore, N. D., Shuch, B., Soule, H. R., Tomlins, S. A., Trabulsi, E. J., Uzzo, R., Vander Griend, D. J., Walsh, P. C., Weil, C. J., Wender, R., & Gomella, L. G.
Venue
Journal of Clinical Oncology
Published
2018-02-01
Volume
36
Issue
4
Pages
414-424
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2774213581
Cited by
191
References
6
FWCI
13.91
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. https://app.cochat.ai/papers/10.1200/jco.2017.74.1173
The paper
Giri, V. N., Knudsen, K. E., Kelly, W. K., Abida, W., Andriole, G. L., Bangma, C. H., Bekelman, J. E., Benson, M. C., Blanco, A., Burnett, A., Catalona, W. J., Cooney, K. A., Cooperberg, M., Crawford, D. E., Den, R. B., Dicker, A. P., Eggener, S., Fleshner, N., Freedman, M. L., . . . Gomella, L. G. (2018). Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2017.74.1173

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.